Catalyst Wire Dossier Catalyst Wire Dossier

Bemalenograstim Alfa

Bemalenograstim alfa
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bemalenograstim Alfa, covering 2023-11-18 to 2023-11-18. Get the full timeline:

Most recent: Clinical Trial Update: Bemalenograstim Alfa for the Prevention in Patients With Colorectal Cancer/Pancreatic Cancer [Phase 2]

See pricing